Clinical Trial

CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

Recruiting
View on ClinicalTrials.gov →
Summary
The primary goal of the study is to obtain effect size data on the use of Shockwave Intravascular Lithotripsy (IVL) technology in calcified common femoral lesions in patients with peripheral artery disease for a series of endpoints, including target lesion revascularization and health status, to enable future planning of comparative effectiveness research.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-06-01 -> 2026-12-31 2026-08-15
Trial Details
NCT Number NCT05145478
Lead Sponsor Yale University
Collaborators: Shockwave Medical, Inc., Brown University
Conditions Femoral Arterial Calcification, Peripheral Arterial Disease, Claudication, Critical Limb Ischemia
Enrollment 50 participants
Start Date 2021-12-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-14